{"id":"W2553727767","doi":"10.1182/blood.v106.11.4619.4619","title":"A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Idarubicin; Cytarabine; Etoposide; Mitoxantrone; Medicine; Internal medicine; Nuclear medicine; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002921699,0.002306605,0.003339011,0.000408054,0.0005558107,0.001320443,0.001650466,0.001849355,0.006116241],"category_scores_gemma":[0.00266277,0.0008353409,0.002785246,0.0006561152,0.001664098,0.001207654,0.0006745324,0.003598957,0.001239407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001783795,"about_ca_system_score_gemma":0.002508981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003767235,"about_ca_topic_score_gemma":0.005859322,"domain_scores_codex":[0.9986438,0.0008043961,0.00008860968,0.0002197969,0.00007273266,0.0001706492],"domain_scores_gemma":[0.9979151,0.0004821091,0.0004805076,0.000241643,0.0001436622,0.0007369079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9936805,0.002395779,0.0003800146,0.00009434535,0.0004260294,0.00001127386,0.00001799085,0.0001033181,0.0006069871,0.00003319855,0.0001807876,0.002069795],"study_design_scores_gemma":[0.9495547,0.04807655,0.001318091,0.00001303354,0.0003818025,0.00001758184,0.00001503182,0.0001652081,0.0001407178,0.00005676033,0.0002525788,0.000007991893],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908926,0.00207373,0.0003789227,0.0006950562,0.0005764145,0.003256646,0.0009360316,0.0000605023,0.00113002],"genre_scores_gemma":[0.9864271,0.00140335,0.001489879,0.001257847,0.0006805288,0.00430028,0.001801059,0.00002779703,0.00261222],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006116241,"threshold_uncertainty_score":0.02046084,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01351699468395368,"score_gpt":0.2718383185078674,"score_spread":0.2583213238239137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}